Radl J, Croese J W, Zurcher C, van den Enden-Vieveen M H, Brondijk R J, Kazil M, Haaijman J J, Reitsma P H, Bijvoet O L
Cancer. 1985 Mar 1;55(5):1030-40. doi: 10.1002/1097-0142(19850301)55:5<1030::aid-cncr2820550518>3.0.co;2-y.
The effects of the treatment of multiple myeloma (MM) with APD-bisphosphonate on bone destruction, the dissemination pattern of the MM, and toxicity for normal and malignant cells were investigated in an animal model, the 5T2 MM. This mouse MM very closely resembles the human disease, including the typical bone lesions. It was demonstrated by radiography, microradiography, and histologic investigation that the treatment of the 5T2 MM with APD-bisphosphonate protected the mice against a loss of bone to a significant extent. It seemed that the treatment with APD not only diminished the bone destruction by the MM but also led to the formation of new bone in already-affected bone tissue. The growth pattern of the MM was not substantially influenced by the treatment, even though there was an indication that APD exerts some cytotoxic effect on the MM cells.
在5T2多发性骨髓瘤动物模型中,研究了APD - 双膦酸盐治疗多发性骨髓瘤(MM)对骨破坏、MM播散模式以及对正常细胞和恶性细胞毒性的影响。这种小鼠MM与人类疾病非常相似,包括典型的骨病变。通过X线摄影、显微放射摄影和组织学研究表明,用APD - 双膦酸盐治疗5T2 MM可在很大程度上保护小鼠免于骨质流失。似乎用APD治疗不仅减少了MM对骨的破坏,而且还导致在已受影响的骨组织中形成新骨。尽管有迹象表明APD对MM细胞有一定的细胞毒性作用,但MM的生长模式并未受到该治疗的实质性影响。